L'Institut du Cerveau et de la Moelle Epiniere;L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE;LAIR LIQUIDE; SOCIETE ANONYME POUR LETUDE ET LEXPLOITATION DES PROCEDES GEORGES CLAUDE
发明人:
MICHEL, Patrick,LAVAUR, Jérémie,HIRSCH, Etienne,LEMAIRE, Marc
申请号：
EP15736546.1
公开号：
EP3157513B1
申请日:
2015.06.08
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The invention relates to a drug combination including gaseous xenon and at least one NMDA receptor antagonist in liquid or solid form. In order to treat or slow tumour proliferation of cells in the contral nervous system in a human being, in particular astrocyte glia and/or the percursors thereof. The NMDA receptor antagonist is perferably memantine or altromemantine. The proportion of xenonis 10% to 80% by volume.
